Ghavamiol

ID: ALA3616593

Chembl Id: CHEMBL3616593

PubChem CID: 122189582

Max Phase: Preclinical

Molecular Formula: C9H19NO9S

Molecular Weight: 317.32

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=S(=O)(O)O[C@@H](CO)[C@@H](O)CN1C[C@@H](O)[C@H](O)[C@H]1CO

Standard InChI:  InChI=1S/C9H19NO9S/c11-3-5-9(15)7(14)2-10(5)1-6(13)8(4-12)19-20(16,17)18/h5-9,11-15H,1-4H2,(H,16,17,18)/t5-,6+,7-,8+,9-/m1/s1

Standard InChI Key:  GQJNTGWORHHLED-QKCLAQEOSA-N

Alternative Forms

  1. Parent:

    ALA3616593

    ---

Associated Targets(non-human)

AMY1.1 Alpha-amylase type A isozyme (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AMY2 Pancreatic alpha-amylase (211 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 317.32Molecular Weight (Monoisotopic): 317.0781AlogP: -4.07#Rotatable Bonds: 7
Polar Surface Area: 167.99Molecular Species: ACIDHBA: 9HBD: 6
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: -1.80CX Basic pKa: 7.05CX LogP: -5.25CX LogD: -5.65
Aromatic Rings: 0Heavy Atoms: 20QED Weighted: 0.25Np Likeness Score: 1.94

References

1. Al-Asri J, Fazekas E, Lehoczki G, Perdih A, Görick C, Melzig MF, Gyémánt G, Wolber G, Mortier J..  (2015)  From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors.,  23  (20): [PMID:26395057] [10.1016/j.bmc.2015.09.007]

Source